期刊文献+

肾性贫血的检测及其规范化治疗 被引量:3

Laboratory diagnosis and standard therapy of chronic anemia
下载PDF
导出
作者 陈楠
出处 《临床内科杂志》 CAS 2005年第11期723-725,共3页 Journal of Clinical Internal Medicine
  • 相关文献

参考文献10

  • 1Thomas MC,Maclsaac RJ,Tsalamandris C ,et al. The burden of anemia in type 2 diabetes and the role of nephropathy:a cross-sectional audit.Nephrol Dial transplant ,2004,19:1992-1997.
  • 2Abramson JL, Jurkovitz CT, Vaccarino V, et al. Chronic kidney disease,anemia and incident stroke in a middle-aged, community-based population: The ARIC study. Kidney Int,2003,64:610-615.
  • 3Rao M, Pereira BJG. Optimal anemia management reduces cardiovascular morbidity, mortality and costs in chronic kidney disease, 2005,68:1432.
  • 4NKF-DOQI. Clinical practice guidelines: Treatment of anemia of chronic renal failure. Am J Kidney Dis ,2001,37 (suppl 1 ) :S182-S238.
  • 5European best practice guidelines for the management of anemia in patients with chronic renal failure. Summary report from Nephrology Dialysis Transplantatiion, 1999:14,120.
  • 6Van Loo A, Vanholder R, Bemaet P, et al. Recombinant human erythropoietin corrects anemia during the first weeks after renal transplantation:A randomized prospective study. Nephrol Dial Transplant, 1996,11:1815-1821.
  • 7Drueke T. Hyporesponsiveness to recombinant human erythropoietin.Nephrol Dial Tranplant,2001,16(S7) :S 25- S 28.
  • 8Casadevall N, Nataf J, Viron B, et al. Pure red cell aplasia and recombinant erythropoietin. The New England Journal of Medicine, 1995,346:469 -477.
  • 9Lai K-N,Yin JA,Yuan PMP,et al. Effect of hemodialysis on protein C,protein S,and antithrombin Ⅲ levels. Am J Kidney Dis, 1991,17:38-42.
  • 10Vazziri ND. Mechanism of erythropoietin induced hypertension. Am J Kidney Dis,1999,33:821-828.

同被引文献17

  • 1谌贻璞.合理使用促红细胞生成素治疗肾性贫血[J].西藏医药,2004,25(4):19-21. 被引量:6
  • 2金艳慧,王明山,郑加永,袁谦.肾性贫血中未成熟网织红细胞的变化及意义[J].实用医学杂志,2005,21(17):1951-1953. 被引量:10
  • 3包瑾芳 姚建 张辰珠.血管紧张素转换酶抑制剂与促红素对肾性贫血的影响[J].中华医学丛刊,2003,3(1):8-8.
  • 4NKF-DOQI. Chnical practice guidelines:Treatment of anemia of chronic renal failure [J]. Am J Kidney Dis, 2001,37( Suppl 1 ) : S182-S238.
  • 5Rao M, Pereira B J. Optimal anemia management reduces cardiovascular morbidity, mortality, and costs in chronic kidney disease [J]. Kidney Int, 2005,68(4) : 1432-1438.
  • 6Thomas MC, Maclsaac R J, Tsalamandris C, et al. The burden of anemia in type2 diabetes and the role of nephropathy: a cross - section audit[ J ]. Nephml Dial transplant,2004,19 : 1992-1997.
  • 7Abramson JL, Jurkovitz CT, Vaccarion V, et al. Chronic kidney disease, anemia and incident stroke in a middle - aged, community - based population :The ARIC study [ J ]. Kidney Int,2003,64:610- 615.
  • 8Consensus Development Conference Panel. Morbidity and mortality of renal dialysis: An NIH consensus conference statement [ J 1. Ann Intern Med, 1994,121 : 62-70.
  • 9Rao M,Pereira BJG. Optimal anemia management reduces cardiovascular morbidity, mortality, and costs in chronic kidney disease[ J]. Kidney international,2005,68 (4) : 1432-1438.
  • 10NKF - DOQI. Clinical practice guidelines : Identifying patients and initiating evaluation[ ] ]. Am J Kidney Dis, 2006,47 ( Suppl 3 ) : S17-$85,.

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部